APT Medical Financials
| 688617 Stock | 362.62 10.47 2.97% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 607.1 M | 578.2 M |
|
|
APT | Select Account or Indicator |
Understanding current and past APT Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of APT Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in APT Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of APT Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, APT Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of APT Medical's management manipulating its earnings.
APT Medical Stock Summary
APT Medical competes with PetroChina, China Mobile, Ping An, China Petroleum, and China Telecom. APT Medical is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100004C45 |
| Business Address | Room 601, Building |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.aptmed.com |
| Phone | 86 755 8359 1013 |
You should never invest in APT Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of APT Stock, because this is throwing your money away. Analyzing the key information contained in APT Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
APT Medical Key Financial Ratios
APT Medical's financial ratios allow both analysts and investors to convert raw data from APT Medical's financial statements into concise, actionable information that can be used to evaluate the performance of APT Medical over time and compare it to other companies across industries.| Revenue | 1.65 B | ||||
| Gross Profit | 1.22 B | ||||
| EBITDA | 749.44 M | ||||
| Net Income | 535.62 M | ||||
| Total Asset | 2.57 B |
APT Medical Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 561.0M | 588.7M | 2.0B | 2.2B | 2.6B | 1.3B | |
| Other Current Liab | 56.6M | 85.5M | 143.8M | 327.1M | 4.8M | 4.6M | |
| Net Debt | 64.4M | (81.3M) | (263.1M) | (198.3M) | (178.5M) | (169.5M) | |
| Retained Earnings | 139.7M | 238.9M | 405.3M | 686.1M | 1.1B | 1.2B | |
| Accounts Payable | 11.0M | 8.4M | 21.1M | 41.2M | 42.7M | 21.6M | |
| Cash | 73.5M | 120.3M | 309.7M | 250.9M | 1.3B | 1.3B | |
| Inventory | 142.8M | 145.3M | 263.2M | 337.9M | 328.0M | 210.8M | |
| Other Current Assets | 1.1M | 28.1M | 4.4M | 5.5M | 7.3M | 13.6M | |
| Total Liab | 215.1M | 138.6M | 222.0M | 434.9M | 611.0M | 641.5M | |
| Total Current Assets | 274.3M | 350.3M | 1.6B | 1.6B | 1.8B | 920.6M | |
| Short Term Debt | 33.8M | 15.5M | 29.6M | 43.5M | 50.1M | 52.6M | |
| Intangible Assets | 103.8M | 32.5M | 32.4M | 38.9M | 83.0M | 46.0M |
APT Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 257.6K | 831.0K | 1.6M | 1.5M | 3.7M | 3.9M | |
| Total Revenue | 404.0M | 479.4M | 828.7M | 1.2B | 1.7B | 1.7B | |
| Gross Profit | 286.1M | 337.3M | 575.8M | 865.9M | 1.2B | 1.2B | |
| Operating Income | 92.1M | 119.4M | 222.5M | 397.0M | 578.2M | 607.1M | |
| Ebit | 92.1M | 119.4M | 222.5M | 397.0M | 456.5M | 479.4M | |
| Research Development | 70.4M | 71.9M | 134.9M | 174.9M | 237.9M | 124.7M | |
| Ebitda | 109.1M | 145.4M | 245.2M | 460.0M | 529.0M | 555.5M | |
| Cost Of Revenue | 117.9M | 142.1M | 252.8M | 350.2M | 474.2M | 497.9M | |
| Income Before Tax | 91.4M | 121.2M | 221.6M | 395.1M | 596.4M | 626.2M | |
| Net Income | 82.6M | 110.8M | 207.9M | 358.0M | 533.9M | 560.6M | |
| Income Tax Expense | 13.3M | 17.0M | 26.7M | 55.0M | 63.2M | 66.4M |
APT Medical Key Cash Accounts
Cash flow analysis captures how much money flows into and out of APT Medical. It measures of how well APT is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money APT Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money APT had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what APT Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (62.7M) | (2.4M) | (124.2M) | (72.6M) | 11.2M | 11.8M | |
| Change In Cash | (17.2M) | 46.8M | 189.3M | (60.7M) | 1.0B | 1.1B | |
| Free Cash Flow | (12.7M) | 104.0M | 14.0M | 224.3M | 487.0M | 511.4M | |
| Change In Working Capital | (42.9M) | 22.1M | (45.6M) | (33.1M) | 95.2M | 100.0M | |
| Begin Period Cash Flow | 90.8M | 73.5M | 120.3M | 309.7M | 249.0M | 159.0M | |
| Other Cashflows From Financing Activities | 15.9M | 15.0M | 1.2B | (149.7M) | (172.2M) | (163.6M) | |
| Depreciation | 14.7M | 20.0M | 33.4M | 48.3M | 64.8M | 68.1M | |
| Other Non Cash Items | 5.0M | 1.9M | (1.3M) | 12.1M | 4.1M | 3.4M | |
| Dividends Paid | 6.0M | 1.4M | 33.2M | 69.0M | 112.2M | 117.8M | |
| Capital Expenditures | 67.6M | 44.2M | 167.4M | 143.2M | 202.0M | 107.1M | |
| Total Cash From Operating Activities | 54.9M | 148.2M | 181.4M | 367.5M | 689.1M | 723.5M | |
| Net Income | 78.1M | 104.2M | 194.9M | 340.2M | 535.6M | 562.4M | |
| Total Cash From Financing Activities | (3.2M) | (101.6M) | 1.1B | (294.6M) | (338.8M) | (321.8M) | |
| End Period Cash Flow | 73.5M | 120.3M | 309.7M | 249.0M | 1.3B | 1.3B |
APT Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining APT Medical's current stock value. Our valuation model uses many indicators to compare APT Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across APT Medical competition to find correlations between indicators driving APT Medical's intrinsic value. More Info.APT Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.54 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for APT Medical is roughly 1.86 . Comparative valuation analysis is a catch-all model that can be used if you cannot value APT Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for APT Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.APT Medical Systematic Risk
APT Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. APT Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on APT Medical correlated with the market. If Beta is less than 0 APT Medical generally moves in the opposite direction as compared to the market. If APT Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one APT Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of APT Medical is generally in the same direction as the market. If Beta > 1 APT Medical moves generally in the same direction as, but more than the movement of the benchmark.
APT Medical Total Assets Over Time
APT Medical Thematic Clasifications
APT Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
APT Medical November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of APT Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of APT Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of APT Medical based on widely used predictive technical indicators. In general, we focus on analyzing APT Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build APT Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.34 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 31.11 | |||
| Value At Risk | (4.56) | |||
| Potential Upside | 4.28 |
Complementary Tools for APT Stock analysis
When running APT Medical's price analysis, check to measure APT Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy APT Medical is operating at the current time. Most of APT Medical's value examination focuses on studying past and present price action to predict the probability of APT Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move APT Medical's price. Additionally, you may evaluate how the addition of APT Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |